Lupin gets FDA tentative approval for generic of contraceptive pill
Lupin Limited has secured tentative approval for its Abbreviated New Drug Application (ANDA) for Drospirenone Tablets, 4 mg from the US Food and Drug Administration (FDA). According to the Indian pharma company, Drospirenone Tablets, 4 mg is the generic version of Slynd Tablets, 4 mg of Exeltis USA. Slynd Tablets (drospirenone) is an oral contraceptive. […]